Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!

BPC-157 Need to know information, Dosing Guides, Suggested Stacks to maximize accelerates wound healing, promotes tendon repair, promotes ligament repair....

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

How much do I take?

Is this right for me?

How do I use it?

Is it safe?

How do I know it's working?

Compound Profile

Scientific & Efficacy Data

C62H98N16O22

Molecular Formula

1419.53 g/mol

Molecular Weight

4-6 hours

Half-Life

~100% (subcutaneous)

Bioavailability

137525-51-0

CAS #

9941444

PubChem ID ↗

Developed By · 1992

Predrag Sikirić

University of Zagreb

Primary Benefits

Accelerates wound healing

Promotes tendon repair

Promotes ligament repair

Amino Acid Sequence

Dosing

How muchdo I take?

Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.

Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.

Starting Dose

250 mcg

Frequency

Once daily

Duration

1-2 weeks

A common starting amount in research practice, often injected near the injured area. BPC-157 has no human dose-finding trials, so doses come from animal studies and documented practice [1][2].

Standard Dose

250-500 mcg

Twice daily

4-6 weeks

Commonly used range for tissue and tendon recovery in research practice [1][3].

Advanced Dose

500 mcg

6-8 weeks

Upper end used in practice for more demanding acute injuries [1][3].

Timing

Best time to take

Administer at a consistent time each day. Consistency matters more than the specific time of day.

With food?

Food timing does not significantly affect absorption for injectable peptides.

If stacking

If combining BPC-157 with other peptides, space administrations by 15-30 minutes. Consult your healthcare provider before combining with prescription medications.

Adjusting Your Dose

Increase if

+Current dose is well-tolerated for 2+ weeks

+Desired effects not yet noticeable

+Healthcare provider recommends dose increase

Decrease if

-Side effects become bothersome or persistent

-Desired effects achieved at lower dose

-Healthcare provider recommends reduction

Signs of right dose

✓Noticeable improvement in target symptoms

✓Good tolerance with minimal side effects

✓Consistent positive response between doses

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Suitability

Is thisright for me?

Best For

Tendon and ligament injuries

Sprains, strains, tears, tendinitis - BPC-157 accelerates collagen synthesis and tissue repair

Gut healing

IBS, leaky gut, ulcers, inflammatory bowel conditions - derived from gastric juice, it has a natural affinity for digestive tissue

Muscle injuries

Strains, post-workout recovery, chronic muscle issues - promotes angiogenesis and growth factor expression

Joint problems

Arthritis support, joint pain, cartilage issues - anti-inflammatory and regenerative properties

Post-surgical recovery

Accelerating healing after procedures - works systemically to enhance the body's repair mechanisms

Consider Alternatives If

Goal: Weight loss

Consider: Tirzepatide, Semaglutide

Goal: Growth hormone optimization

Consider: CJC-1295, Ipamorelin

Goal: Cognitive enhancement

Consider: Semax, Selank

Goal: Anti-aging / skin

Consider: GHK-Cu, Epithalon

Who Should Avoid

Do not use if

×Pregnancy

×Breastfeeding

×Active cancer

×History of cancer

Use with caution if

!You have any chronic medical conditions

!You are taking prescription medications

!You have a history of allergic reactions to peptides

Not Sure?

Compare BPC-157 with similar peptides to find the best fit for your goals.

Administration

How do Iuse it?

Reconstitution

What you need

•Bacteriostatic water (BAC water)

•Insulin syringes (29-31 gauge)

•Alcohol swabs

•Sharps container

Example

If using a standard vial, add bacteriostatic water to achieve your desired concentration. For example, adding 2mL of BAC water to a vial allows precise dosing with an insulin syringe.

Draw up the appropriate volume based on your reconstitution ratio. Consult dosing charts for exact volumes corresponding to 250-500 mcg doses.

Injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)

Best sites

•Lower abdomen (2 inches from navel)

•Outer thigh (middle third)

•Back of upper arm

Technique

1.Wash hands and prepare clean workspace

2.Clean injection site with alcohol swab

3.Draw correct dose into insulin syringe

4.Pinch skin and insert needle at 45-90 degree angle

5.Inject slowly, withdraw needle

6.Apply gentle pressure—do not rub

7.Dispose of syringe in sharps container

Storage

Before reconstitution

Store in refrigerator at 36-46°F (2-8°C). Keep in original packaging to protect from light. Do not freeze.

After reconstitution

Store reconstituted solution in refrigerator at 36-46°F (2-8°C). Use within 30 days. Do not freeze reconstituted solution.

Signs of degradation

Solution appears cloudy or discolored

Visible particles or precipitates in solution

Solution has changed color from original appearance

Vial has been exposed to temperatures above 77°F (25°C) for extended periods

Sample Daily Schedule

Morning (8:00 AM)

250mcg injection

Site: Near injury or abdomen

Administer via subcutaneous injection in the morning for consistency. Inject near the site of injury for optimal localized healing effects, or in the abdomen for systemic benefits.

Evening (8:00 PM)

Site: Rotate from morning

Duration: Continue for 4-6 weeks. Then: 2-4 week break before restarting if needed.

Safety

Is itsafe?

Safety Profile

BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds. Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.

BPC-157's evidence base is categorized as 'Strong preclinical' based on extensive rat models demonstrating accelerated healing across multiple tissue types including tendon, ligament, muscle, and GI mucosa. However, no completed Phase 3 human clinical trials exist. Published human data is limited to a small number of early-phase studies and case reports. Manufacturing quality varies significantly between suppliers as the compound is not regulated by the FDA.

Common Side Effects

Experienced by some users

Injection site redness

Usually resolves in 30-60 minutes

Management: Rotate sites, ice if needed

Mild nausea

Typically only first few doses

Management: Take with food, reduce dose temporarily

Dizziness

Rare, usually with higher doses

Management: Reduce dose, stay hydrated

Less Common

•Headache

•Fatigue

•Hot/cold sensations

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×If you experience severe or persistent injection site reactions or signs of infection

×If you develop signs of an allergic reaction such as difficulty breathing, swelling, or severe rash

×If healing progress plateaus after 6+ weeks of continuous use, indicating need for reassessment or alternative approaches

Always consult with a healthcare provider before discontinuing BPC-157, especially if used for active injury recovery. Do not stop abruptly without medical guidance as this may impact healing outcomes.

Interactions

With other peptides

✓TB-500

✓GHK-Cu

✓CJC-1295 + Ipamorelin

With medications

!Blood Thinners - Blood Thinners (Warfarin

!etc.) - etc.)

!NSAIDs - NSAIDs (Ibuprofen

With supplements

✓Vitamin D3 - Generally safe and may support overall health

✓Magnesium - Generally safe and may enhance peptide absorption

Effectiveness

Does itwork?

Evidence Level

Strong preclinical

What to Expect

Week 1-2

What you might notice

•Reduced inflammation

•Less pain at injury site

•Improved gut comfort (if used for digestive issues)

What's normal

•Subtle changes—don't expect dramatic results yet

•Some users feel nothing this early

What's next

→Continue protocol

→Maintain consistent timing

Week 3-4

•Noticeable improvement in injury healing

•Increased mobility

•Better function in affected area

•Significant gut symptom relief

•This is when most users see clear benefits

•Progress may be gradual, not sudden

→Assess if dose adjustment needed

→Continue if seeing progress

Week 5-6+

•Substantial or complete healing

•Return to normal activity

•Lasting improvements

•Healing timeline varies by injury severity

•Some chronic conditions need longer

→Consider stopping if healed

→Take 2-4 week break

→Can restart if needed

Signs It's Working

For injuries

✓Less pain at rest

✓Less pain with movement

✓Improved range of motion

✓Faster recovery between workouts

✓Reduced swelling

For gut issues

✓Less bloating

✓Reduced pain after eating

✓More regular digestion

✓Decreased symptoms overall

Not Seeing Results?

Common reasons

•Not allowing enough time—most peptides require consistent use for weeks to months before full effects are apparent

•Inconsistent dosing schedule—maintaining regular administration is critical for optimal results

•Improper storage or handling leading to degraded product

•Individual variation in response—genetics, health status, and other factors affect how you respond

•Dose may need adjustment—consult with your healthcare provider about optimizing your protocol

Key Research

[1]"BPC 157 and its role in healing"

Sikiric et al., 2018

Finding: Demonstrated healing across multiple tissue types including tendon, ligament, muscle, and gut lining with no observed toxicity.

[2]"Gastric pentadecapeptide BPC 157 and wound healing"

Seiwerth et al., 2014

Finding: Accelerated wound closure and tissue regeneration in multiple animal models.

[3]"Effect of BPC 157 on tendon healing"

Chang et al., 2011

Finding: Significantly improved tendon-to-bone healing in rat rotator cuff model.

Organ Targets

Powered by Human Organ Atlas

Organs and body systems affected by BPC-157, mapped to the Human Organ Atlas — an open-access 3D portal featuring 56 organs imaged at near-cellular resolution.

Stomach & GI Tract

Digestive System

Accelerates healing of gastric ulcers, repairs intestinal lining, and protects against NSAID-induced gut damage

Liver

Supports hepatoprotective effects and promotes liver tissue repair

Heart

Cardiovascular System

Promotes angiogenesis and supports cardiovascular tissue repair

Brain

Nervous System

Neuroprotective effects, supports dopaminergic and serotonergic systems

The Science

Stacking & Combinations

Frequently Asked Questions

How long does BPC-157 take to work?

Can I take BPC-157 orally?

Should I inject near the injury site?

Can I stack BPC-157 with other peptides?

Do I need to cycle BPC-157?

Technical Specifications

Connected topics

Follow this recovery question